KAYDI LENTZ: Open Payments
NPI 1831649110 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$362 in 12 payments from 8 companies in 2025. Trend: 2023 $610 · 2024 $0 · 2025 $362
Food & beverage: $277Education: $85
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 3 | $131 |
| GENZYME CORPORATION | 3 | $99 |
| Boston Scientific Corporation | 1 | $25 |
| UCB, Inc. | 1 | $25 |
| Amgen Inc. | 1 | $24 |
| Botanix SB Inc | 1 | $22 |
| Incyte Corporation | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: DUPIXENT, General - Pain Management, Bimzelx, OTEZLA, SOFDRA, OPZELURA, COSENTYX.
Industry payments across NY — which companies pay providers there.
